CC
XFOR icon

Caxton Corporation’s X4 Pharmaceuticals XFOR Stock Holding History

Caxton Corporation’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.2K Hold
15,557
– – 1.6% 5
2025
Q4 		$62.2K Buy
+15,557
New +$56.5K 1.45% 8

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Caxton Corporation's XFOR Position: Q1 2026 in Review

Caxton Corporation held its X4 Pharmaceuticals (XFOR) position steady in Q1 2026 at 15,557 shares worth $64.2K. The position accounts for 1.6% of the portfolio, ranked #5.

Caxton Corporation first reported a position in XFOR in Q4 2025 and has held it in 2 quarters since. 84 funds tracked by Wall St. Rank hold XFOR as of Q1 2026.

  • Caxton Corporation held 15,557 shares of X4 Pharmaceuticals worth $64.2K as of Q1 2026.
  • Caxton Corporation left its X4 Pharmaceuticals share count unchanged in Q1 2026.
  • X4 Pharmaceuticals made up 1.6% of Caxton Corporation's portfolio in Q1 2026, its #5 holding.
  • Caxton Corporation first reported a position in X4 Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 84 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2026.

Based on Caxton Corporation's 13F filing for Q1 2026, filed 14 May 2026.